Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/18180
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Duchenne, Jurgen | - |
dc.contributor.author | VERBRUGGE, Frederik | - |
dc.contributor.author | DUPONT, Matthias | - |
dc.contributor.author | Vercammen, Jan | - |
dc.contributor.author | Jacobs, Linda | - |
dc.contributor.author | GRIETEN, Lars | - |
dc.contributor.author | VANDERVOORT, Pieter | - |
dc.contributor.author | MULLENS, Wilfried | - |
dc.date.accessioned | 2015-01-23T13:39:43Z | - |
dc.date.available | 2015-01-23T13:39:43Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | ACTA CARDIOLOGICA, 69 (2), p. 145-154 | - |
dc.identifier.issn | 0001-5385 | - |
dc.identifier.uri | http://hdl.handle.net/1942/18180 | - |
dc.description.abstract | Objective The objective of this study was to assess the feasibility and impact on readmissions of transmural disease management across the borders of the cardiology department in patients with advanced heart failure (HF). Methods and results Consecutive patients, readmitted within one year for advanced HF by a dedicated specialist (n = 55), were followed for 22 10 months after implementation of a hospitalwide transmural disease management strategy. Participants received a tag in their electronic medical record, triggering a HF caregiver contact, with subsequent guideline-recommended, protocol-driven care on each cardiac or non-cardiac hospitalization as well as outpatient evaluation. Upon transition to outpatient follow-up, patients were instructed to call the HF caregiver with any question at low threshold. Readmission rates were prospectively collected. Despite receiving adequate treatment with neurohumoral blockers, patients (71 +/- 11 years; ejection fraction 35 +/- 13%) had spent 4% (27%) of the year preceding study inclusion in hospital, with 73% admitted once, 20% twice, and 7% more than twice for acute decompensated HF (ADHF). During the study, patients were exposed to 6 4 dedicated HF caregiver contacts. Participation in remote device monitoring increased from 31% to 92%, with 1(0-3) additional phone contacts per patient-year of follow-up in this subgroup (n = 24). All-cause mortality and readmission rates for ADHF were 10% and 25% after one year, and 19% and 39% after 2 years, respectively. Follow-up time spent in hospital decreased significantly to 2% (16%) (P value = 0.047). Conclusions Follow-up of advanced HF patients through transmural disease management is feasible and associated with favourable clinical outcome. | - |
dc.description.sponsorship | No grants, contracts or other forms of financial support were given to support publication of this manuscript. Dr. Verbrugge and Dr. Mullens are researchers for the Limburg Clinical Research Program (LCRP) UHasselt-ZOL, supported by the foundation Limburg Sterk Merk (LSM), Hasselt University, Ziekenhuis Oost-Limburg. | - |
dc.language.iso | en | - |
dc.publisher | ACTA CARDIOLOGICA | - |
dc.subject.other | Disease management; heart failure; hospitalization; quality of health care | - |
dc.title | Implementation of transmural disease management in patients admitted with advanced heart failure | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 154 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 145 | - |
dc.identifier.volume | 69 | - |
local.format.pages | 10 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Duchenne, Jurgen; Verbrugge, Frederik H.; Dupont, Matthias; Vercammen, Jan; Jacobs, Linda; Grieten, Lars; Vandervoort, Pieter; Mullens, Wilfried] Ziekenhuis Oost Limburg, Dept Cardiol, B-3600 Genk, Belgium. [Duchenne, Jurgen] Transnat Univ Limburg, Fac Med & Life Sci, Dept Life Sci, Hasselt, Belgium. [Verbrugge, Frederik H.] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium. [Grieten, Lars; Vandervoort, Pieter; Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Diepenbeek, Belgium. | - |
local.publisher.place | BRUSSELS | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.2143/AC.69.2.3017295 | - |
dc.identifier.isi | 000346681200005 | - |
item.contributor | Duchenne, Jurgen | - |
item.contributor | VERBRUGGE, Frederik | - |
item.contributor | DUPONT, Matthias | - |
item.contributor | Vercammen, Jan | - |
item.contributor | Jacobs, Linda | - |
item.contributor | GRIETEN, Lars | - |
item.contributor | VANDERVOORT, Pieter | - |
item.contributor | MULLENS, Wilfried | - |
item.accessRights | Open Access | - |
item.fullcitation | Duchenne, Jurgen; VERBRUGGE, Frederik; DUPONT, Matthias; Vercammen, Jan; Jacobs, Linda; GRIETEN, Lars; VANDERVOORT, Pieter & MULLENS, Wilfried (2014) Implementation of transmural disease management in patients admitted with advanced heart failure. In: ACTA CARDIOLOGICA, 69 (2), p. 145-154. | - |
item.fulltext | With Fulltext | - |
item.validation | ecoom 2016 | - |
crisitem.journal.issn | 0001-5385 | - |
crisitem.journal.eissn | 1784-973X | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Peeters (6).pdf | 1.2 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
4
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
3
checked on Apr 22, 2024
Page view(s)
52
checked on Jul 20, 2022
Download(s)
212
checked on Jul 20, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.